Abstract:The human γ-aminobutyric acid (GABA) transporter 1 (hGAT-1) is the first member of the solute carrier 6 (SLC6) protein superfamily. GAT-1 ( SLC6A1 ) is one of the main GABA transporters in the central nervous system. Its principal physiological role is retrieving GABA from the synapse into neurons and astrocytes, thus swiftly terminating neurotransmission. GABA is a key inhibitory neurotransmitter and shifts in GABAergic signaling can lead to pathological conditions, from anxiety and epileptic seizures to schizophrenia. Point mutations in the SLC6A1 gene frequently give rise to epilepsy, intellectual disability or autism spectrum disorders in the afflicted individuals. The mechanistic routes underlying these are still fairly unclear. Some loss-of-function variants impair the folding and intracellular trafficking of the protein (thus retaining the transporter in the endoplasmic reticulum compartment), whereas others, despite managing to reach their bona fide site of action at the cell surface, nonetheless abolish GABA transport activity (plausibly owing to structural/conformational defects). Whatever the molecular culprit(s), the physiological aftermath transpires into the absence of functional transporters, which in turn perturbs GABAergic actions. Dozens of mutations in the kin SLC6 family members are known to exhort protein misfolding. Such events typically elicit severe ailments in people, e.g., infantile parkinsonism-dystonia or X-linked intellectual disability, in the case of dopamine and creatine transporters, respectively. Flaws in protein folding can be rectified by small molecules known as pharmacological and/or chemical chaperones. The search for such apt remedies calls for a systematic investigation and categorization of the numerous disease-linked variants, by biochemical and pharmacological means in vitro (in cell lines and primary neuronal cultures) and in vivo (in animal models). We here give special emphasis to the utilization of the fruit fly Drosophila melanogaster as a versatile model in GAT-1-related studies. Jointly, these approaches can portray indispensable insights into the molecular factors underlying epilepsy, and ultimately pave the way for contriving efficacious therapeutic options for patients harboring pathogenic mutations in hGAT-1.

Overexpression of Γ-Aminobutyric Acid Transporter Subtype I Leads to Susceptibility to Kainic Acid-Induced Seizure in Transgenic Mice

Increase in Drug-Induced Seizure Susceptibility of Transgenic Mice Overexpressing Gaba Transporter-1

Effect of diazoxide on regulation of vesicular and plasma membrane GABA transporter genes and proteins in hippocampus of rats subjected to picrotoxin-induced kindling.

Gaba Transporter-1 Activity Modulates Hippocampal Theta Oscillation And Theta Burst Stimulation-Induced Long-Term Potentiation

Syntaxin 1a Promotes the Endocytic Sorting of Eaac1 Leading to Inhibition of Glutamate Transport

[Ethanol Affects the Function of Gamma-Aminobutyric Acid Transporter I in Mice Brain].

Astrocytic GABA Transporter 1 Deficit in Novel SLC6A1 Variants Mediated Epilepsy: Connected from Protein Destabilization to Seizures in Mice and Humans.

Reduced Aggression in Mice Lacking GABA Transporter Subtype 1.

Mice with genetically altered GABA transporter subtype I (GAT1) expression show altered behavioral responses to ethanol.

Hypoalgesia in mice lacking GABA transporter subtype 1

Cognitive impairment in mice over-expressing gamma-aminobutyric acid transporter 1 (GAT1).

Cognitive impairment in mice over-expressing ??-aminobutyric acid transporter I (GAT1):

Role for Pro-Inflammatory Cytokines in Regulating Expression of GABA Transporter Type 1 and 3 in Specific Brain Regions of Kainic Acid-Induced Status Epilepticus.

Reduced Anxiety and Depression-Like Behaviors in Mice Lacking GABA Transporter Subtype 1

Altered Expression of G Protein-Coupled Inwardly Rectifier Potassium Channels (GIRK) Subunit 1 and 2 in Hippocampus of Chronic Temporal Epileptic Rats Induced by Kainic Acid

G‐alpha Interacting Protein Interacting Protein, C Terminus 1 Regulates Epileptogenesis by Increasing the Expression of Metabotropic Glutamate Receptor 7

GABA Transporter-1 Deficiency Confers Schizophrenia-Like Behavioral Phenotypes

Effect of GABA Receptor Gene Transfection on the Cortical Electroencephalogram of Epileptic Rats

Compensatory Mechanisms Modulate the Neuronal Excitability in a Kainic Acid-Induced Epilepsy Mouse Model.

Overexpressing wild-type γ2 subunits rescued the seizure phenotype in Gabrg2+/Q390X Dravet syndrome mice

Molecular and Clinical Repercussions of GABA Transporter 1 Variants Gone Amiss: Links to Epilepsy and Developmental Spectrum Disorders